Correlation of Clinical Frailty Scale and Modified Frailty Index in Intensive Care Patients

September 6, 2021 updated by: Bahar SAKIZCI UYAR, Diskapi Yildirim Beyazit Education and Research Hospital
The purpose of our study is to evaluate the correlation of the Clinical Frailty Scale, which is a judgment-based measure, and the Modified Frailty Index, which interrogates the patient's current diseases, in the frailty assessment of intensive care patients and the effect on the estimation of mortality, mechanical ventilation need, intensive care stay, hospital stay and discharge status.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

intensive care patients

Description

Inclusion Criteria:

  • intensive care patients

Exclusion Criteria:

  • patients with a life expectancy of less than 24 hours
  • Do not speak Turkish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty
Time Frame: in the first 24 hours of intensive care admissions
the correlation of the Clinical Frailty Scale, which is a judgment-based measure, and the Modified Frailty Index, which interrogates the patient's current diseases, in the frailty assessment of intensive care patients
in the first 24 hours of intensive care admissions

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mortality
Time Frame: the patient will be monitored for 1 year and the exitus time will be recorded
effect of the clinical frailty scale and modified farilty index on the estimation of mortality
the patient will be monitored for 1 year and the exitus time will be recorded
intensive care stay
Time Frame: the patient will be monitored for 1 year and the intensive care stay will be recorded
effect of the clinical frailty scale and modified farilty index on the estimation of intensive care stay
the patient will be monitored for 1 year and the intensive care stay will be recorded
discharge status
Time Frame: the patient will be monitored for 1 year and the discharge status will be recorded
effect of the clinical frailty scale and modified farilty index on the estimation of discharge status
the patient will be monitored for 1 year and the discharge status will be recorded

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Diskapi Yildirim Beyazit Education and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Actual)

July 1, 2021

Study Completion (Anticipated)

January 1, 2022

Study Registration Dates

First Submitted

August 13, 2020

First Submitted That Met QC Criteria

August 13, 2020

First Posted (Actual)

August 17, 2020

Study Record Updates

Last Update Posted (Actual)

September 8, 2021

Last Update Submitted That Met QC Criteria

September 6, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 92/04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe